ICRP Publication 94 Release of Patients after Therapy with Unsealed Radionuclides

Name: ICRP Publication 94 Release of Patients after Therapy with Unsealed Radionuclides
Availability: OutOfStock
ISBN: 9780080445601

ISBN-10: 0080445608

ISBN-13: 9780080445601

Edition: 2005

Authors: ICRP

List price: $176.00

30 day, 100% satisfaction guarantee!

Out of stock

We're sorry. This item is currently unavailable.

what's this?

Rush Rewards U
Members Receive:

You have reached 400 XP and carrot coins. That is the daily max!

Description:

After some therapeutic nuclear medicine procedures with unsealed radionuclides, precautions may be needed to limit doses to others, but this is rarely the case after diagnostic procedures. Iodine-131 results in the most dose to medical staff, public, caregivers, and family members. Other radionuclides used in therapy are usually simple beta emitters (e.g. 32P, 89Sr, 90Y) that pose much less hazard. Dose limits apply to the exposure of the public and medical staff from patients. Prior ICRP recommendations are that no dose limit but a source-related dose constraint for optimisation of a few mSv per episode applies to the family, visitors, and caregivers at home. Here, it is recommended that…

Book details

List price: $176.00
Copyright year: 2005
Publisher: SAGE Publications, Limited
Publication date: 5/25/2005
Binding: Paperback
Pages: 84
Size: 6.50" wide x 9.00" long x 0.25" tall
Weight: 0.374
Language: English



Types And Frequency Of Nuclear Medicine Procedures


Radiation Protection After Use Of Therapeutic Radiopharmaceuticals Current


International Recommendations On Dose Limits And Dose Constraints Critical


Pathways Of Exposure From Iodine-131 Magnitude And Nature Of Risk From Iodine-131


Exposure For Relatives, Caregivers, And The Public Environmental Pathways Of Radioiodine


Disposal Of Radioactive Waste From Therapy With Unsealed Radionuclides


Decision To Hospitalise Or Release Patients International And National


Guidance On Release Criteria Antibody Therapy